UBS Group’s Insmed INSM Stock Holding History

UBS Group’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-37,600	Closed	-$6.54M	–	10817
2025 Q4	$6.54M	Hold	37,600	–	–	﹤0.01%	3748
2025 Q3	$5.41M	Buy	+37,600	New	+$4.61M	﹤0.01%	3955
2025 Q2	–	Sell	-5,000	Closed	-$381K	–	10536
2025 Q1	$381K	Buy	5,000 +1,200	+32%	+$91.8K	﹤0.01%	6075
2024 Q4	$262K	Buy	+3,800	New	+$274K	﹤0.01%	6289
2022 Q4	–	Sell	-9,000	Closed	-$194K	–	10914
2022 Q3	$194K	Buy	+9,000	New	+$216K	﹤0.01%	5107

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

UBS Group's INSM Position: Q1 2026 in Review

UBS Group reduced its Insmed (INSM) stake by 7% in Q1 2026, selling an estimated $20M and leaving 1,737,481 shares worth $284M. The position accounts for 0.04% of the portfolio, ranked #454.

UBS Group first reported a position in INSM in Q4 2014 and has held it in 46 quarters since. The position peaked at $325M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

UBS Group held 1,737,481 shares of Insmed worth $284M as of Q1 2026.
UBS Group sold 130,154 Insmed shares in Q1 2026, an estimated $20M.
Insmed made up 0.04% of UBS Group's portfolio in Q1 2026, its #454 holding.
UBS Group first reported a position in Insmed in Q4 2014 and has held it in 46 quarters since.
UBS Group's Insmed position peaked at $325M in Q4 2025.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.